Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Shiv Sehgal discusses investor sentiment, corporate India's outlook, and the impact of global trade issues on the market. He ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

Shota Imanaga will get a Tokyo Series start for the Chicago Cubs as he builds upon his stellar rookie year ...